CASI Pharmaceuticals (CASI)

P/S ratio as of November 2024 (TTM): 3.94

According to CASI Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 10.1. At the end of 2024 the company had a P/S ratio of 3.19.

P/S ratio history for CASI Pharmaceuticals from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	3.19	13.34%
2023	2.82	398.31%
2022	0.5650	-84.76%
2021	3.71	-84.65%
2020	24.1	-66.98%
2019	73.1
2018	N/A
2017	N/A
2016	N/A	-100%
2015	653	-64.1%
2014	> 1000
2013	N/A	-100%
2012	46.4	674.6%
2011	5.99	-62.19%
2010	15.8	18.01%
2009	13.4	1291.02%
2008	0.9651	-86.45%
2007	7.12	-35.12%
2006	11.0	-33.32%
2005	16.5	-93.89%
2004	269	246.41%
2003	77.8	340.77%
2002	17.7	-82.14%
2001	98.8

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for CASI Pharmaceuticals (CASI)